GGrantIndex
Sort

78,016 grants matching breast cancer

Image-guided, Transcatheter Peptide Receptor Radio Therapy for Prostate Cancer

$585,719
Michael F Tweedle · Ohio State University · R01 · FY2019 · EB

Therapeutic agents targeting nuclear receptor signaling in distinct molecular subtypes of breast cancer

$585,712
Ratna K Vadlamudi · University Of Texas Hlth Science Center · R01 · FY2021 · CA

An Electronic Health Record-Based Tool to Identify Newly Diagnosed Breast Cancer Patients at Risk of Low Social Support

$585,693
Candyce H Kroenke · Kaiser Foundation Research Institute · R01 · FY2020 · CA

Understanding the biological basis for the association between parenchymal texture features and breast cancer risk

$585,676
Sarah Jane Nyante · Univ Of North Carolina Chapel Hill · R01 · FY2020 · CA

IDBR: TYPE A Nanoscale Laser Ablation Capture for Single Cell Genomics

$585,664
Kermit K Murray · Louisiana State University · · FY2016 · BIO

High resolution cone beam volume CT for breast imaging

$585,662
Ruola Ning · University Of Rochester · R33 · FY2006 · CA

THE ROLE OF POLY(ADP-RIBOSE) IN MICRORNA ACTIVITY IN BREAST CANCERS

$585,652
The Johns Hopkins University · · FY2011 · Department of the Army

EFFECT OF PASIREOTIDE IN BREAST CANCER PREVENTION IN BRCA1 DEFICIENCY

$585,637
New York University · · FY2011 · Department of Defense

Kansas City Clincal Oncology Program CCOP

$585,600
Rakesh Gaur · Nci Community Oncology Research Program · U10 · FY2013 · CA

Bionanotechnology approach for treatment of lung cancer

$585,581
Tamara Minko · Rutgers, The State Univ Of N.J. · R01 · FY2021 · CA

Bionanotechnology approach for treatment of lung cancer

$585,581
Tamara Minko · Rutgers, The State Univ Of N.J. · R01 · FY2019 · CA

Bionanotechnology approach for treatment of lung cancer

$585,581
Tamara Minko · Rutgers, The State Univ Of N.J. · R01 · FY2020 · CA

Common and rare sequence variants in breast cancer risk

$585,500
Sean Vahram Tavtigian · University Of Utah · R01 · FY2017 · CA

NIGHT SHIFT WORKERS AND HORMONE LEVELS IN WOMEN

$585,495
Scott Davis · Fred Hutchinson Cancer Research Center · R01 · FY2006 · CA

Multi-parameter Nonlinear Elasticity Mapping of Breast Masses

$585,473
Mostafa Fatemi · Mayo Clinic Rochester · R01 · FY2018 · CA

NSAIDs During Postpartum Involution for Breast Cancer Chemoprevention

$585,429
Pepper J Schedin · Oregon Health & Science University · R01 · FY2015 · CA

PROBING HER2-PUMA AND EGFR-PUMA CROSSTALKS IN AGGRESSIVE BREAST CANCER

$585,381
Duke University · · FY2011 · Department of Defense

Combined Methylation and Mutation to Predict Response to PARP Inhibitors

$585,331
Elizabeth Mary Swisher · University Of Washington · R01 · FY2023 · CA

Mobile Device CBT for Chemotherapy-Related Cognitive Dysfunction: A Multi-Center Randomized Controlled Trial

$585,312
Robert J Ferguson · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA

Metabolic Targets in Pten-Tumors

$585,248
Jeffrey A Smith · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2009 · CA

An Exercise Intervention to Improve Health in Postmenopausal Cancer Survivors

$585,231
M. Tish Knobf · Yale University · R01 · FY2010 · CA

Next Generation Rat Models of ER+ Breast Cancer

$585,230
Yi Li · Baylor College Of Medicine · R01 · FY2023 · CA

The resurgence of antibody-drug conjugates via PMPC-polymer engineering

$585,228
Masakazu Kamata · University Of Alabama At Birmingham · R01 · FY2024 · CA

The resurgence of antibody-drug conjugates via PMPC-polymer engineering

$585,228
Masakazu Kamata · University Of Alabama At Birmingham · R01 · FY2025 · CA

EMPOWER Study: Promoting BC Screening in Women Who Survived Childhood Cancer

$585,216
Kevin Charles Oeffinger · Sloan-Kettering Inst Can Research · R01 · FY2013 · CA